je.st
news
Johnson & Johnson Is A Buy
2015-09-10 11:06:23| Biotech - Topix.net
Big capital gains not likely here, but investors will get a 3.3% dividend yield with high-single digit dividend growth and a long runway of growth ahead. The broad market correction has made a handful of great companies reasonable once again.
Tags: buy
johnson
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|